Merck sends controversial cervical cancer shot to FDA

Source: Pharmafocus.com

Date: 12/07/05

Headline: Merck sends controversial cervical cancer shot to FDA

Merck & Co. Inc. has submitted its cervical cancer vaccine Gardasil to the FDA for approval. The vaccine has proven effective in preventing the human papillomavirus (HPV), a sexually transmitted virus which causes most cases of cervical cancer. Cervical cancer is the second biggest cancer killer in women. Controversy has arisen because advocates fear the vaccine will promote promiscuity in young women.


Posted Anonymously Latest page update: made by Anonymous , Feb 22 2006, 7:13 PM EST (about this update About This Update Posted Anonymously updated external link - anonymous

2 words added
2 words deleted

view changes
- complete history)
Keyword tags: cervical FDA human papillomavirus Merck Vaccine women
More Info: links to this page

Threads


There are no threads for this page. 

Anonymous  (Get credit for your thread)

Related Content

  (what's this?Related ContentThanks to keyword tags, links to related pages and threads are added to the bottom of your pages. Up to 15 links are shown, determined by matching tags and by how recently the content was updated; keeping the most current at the top. Share your feedback on Wetpaint Central.)
women interests Links to other Cancer Sites Archive 2006 08 - August
Short-term radiation put to test for breast cancer Weight gain increases breast cancer risk Women need endometrial cancer awareness
Study confirms obesity's role in ovarian cancer Bilingual clinics boost cancer screening for hispanic women Alarm at women's cancer deaths
FDA licenses new vaccine for prevention of cervical cancer